- Home
- PROF vs ALDX Comparison
PROF vs ALDX Comparison
Compare PROF & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- ALDX
- Stock Information
- Founded
- PROF N/A
- ALDX 2004
- Country
- PROF Canada
- ALDX United States
- Employees
- PROF N/A
- ALDX N/A
- Industry
- PROF Medical/Dental Instruments
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- PROF Health Care
- ALDX Health Care
- Exchange
- PROF Nasdaq
- ALDX Nasdaq
- Market Cap
- PROF 149.7M
- ALDX 160.8M
- IPO Year
- PROF N/A
- ALDX 2014
- Fundamental
- Price
- PROF $6.38
- ALDX $3.05
- Analyst Decision
- PROF Strong Buy
- ALDX Strong Buy
- Analyst Count
- PROF 2
- ALDX 2
- Target Price
- PROF $11.50
- ALDX $9.50
- AVG Volume (30 Days)
- PROF 50.0K
- ALDX 769.8K
- Earning Date
- PROF 08-07-2025
- ALDX 07-31-2025
- Dividend Yield
- PROF N/A
- ALDX N/A
- EPS Growth
- PROF N/A
- ALDX N/A
- EPS
- PROF N/A
- ALDX N/A
- Revenue
- PROF $11,862,000.00
- ALDX N/A
- Revenue This Year
- PROF $71.17
- ALDX N/A
- Revenue Next Year
- PROF $134.25
- ALDX N/A
- P/E Ratio
- PROF N/A
- ALDX N/A
- Revenue Growth
- PROF 75.01
- ALDX N/A
- 52 Week Low
- PROF $3.90
- ALDX $1.14
- 52 Week High
- PROF $11.42
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- PROF 69.47
- ALDX 61.89
- Support Level
- PROF $6.69
- ALDX $2.60
- Resistance Level
- PROF $7.02
- ALDX $3.24
- Average True Range (ATR)
- PROF 0.40
- ALDX 0.22
- MACD
- PROF 0.09
- ALDX 0.09
- Stochastic Oscillator
- PROF 69.53
- ALDX 80.93
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.